These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38762336)

  • 1. Healthcare utilization and expenditures among patients with venous thromboembolism following gastrointestinal cancer surgery.
    Khalil M; Woldesenbet S; Munir MM; Khan MMM; Rashid Z; Altaf A; Katayama E; Endo Y; Dillhoff M; Tsai S; Pawlik TM
    J Gastrointest Surg; 2024 Jul; 28(7):1151-1157. PubMed ID: 38762336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of pathologic factors with postoperative venous thromboembolism after gastrointestinal cancer surgery.
    Janczewski LM; Silver CM; Schlick CJR; Odell DD; Bentrem DJ; Yang AD; Bilimoria KY; Merkow RP
    J Gastrointest Surg; 2024 Jun; 28(6):813-819. PubMed ID: 38553295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care expenditures associated with venous thromboembolism among children.
    Boulet SL; Amendah D; Grosse SD; Hooper WC
    Thromb Res; 2012 May; 129(5):583-7. PubMed ID: 21872297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.
    Streiff M; Milentijevic D; McCrae KR; Laliberté F; Lejeune D; Lefebvre P; Schein J; Khorana AA
    J Med Econ; 2019 Nov; 22(11):1134-1140. PubMed ID: 31106638
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs.
    Del Giudice F; Tresh A; Li S; Basran S; Prendiville SG; Belladelli F; DE Berardinis E; Asero V; Scornajenghi CM; Carino D; Ferro M; Rocco B; Busetto GM; Falagario U; Autorino R; Crocetto F; Barone B; Pradere B; Krajewski W; Nowak Ł; Szydełko T; Moschini M; Mari A; Crivellaro S; Porpiglia F; Fiori C; Amparore D; Pichler R; Rane A; Challacombe B; Nair R; Chung BI
    Minerva Urol Nephrol; 2024 Jun; 76(3):320-330. PubMed ID: 38920012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
    J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with cancer undergoing surgical exploration.
    Ruff SM; Weber KT; Khader A; Conte C; Kadison A; Sullivan J; Wang J; Zaidi R; Deutsch GB
    J Thromb Thrombolysis; 2019 Feb; 47(2):316-323. PubMed ID: 30560488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
    Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
    J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer.
    Khorana AA; McCrae KR; Milentijevic D; Laliberté F; Lejeune D; Crivera C; Lefebvre P
    J Med Econ; 2020 Apr; 23(4):323-329. PubMed ID: 31818164
    [No Abstract]   [Full Text] [Related]  

  • 11. Racial differences in symptomatic postoperative venous thromboembolism rates after major oncologic resection.
    Takahashi-Pipkin CJ; Irish W; Parikh AA; Snyder RA
    Surgery; 2021 Dec; 170(6):1770-1776. PubMed ID: 34325904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Perioperative Thromboembolic Complications on Future Long-term Risk of Venous Thromboembolism among Medicare Beneficiaries Undergoing Complex Gastrointestinal Surgery.
    Paro A; Dalmacy D; Hyer JM; Tsilimigras DI; Diaz A; Pawlik TM
    J Gastrointest Surg; 2021 Dec; 25(12):3064-3073. PubMed ID: 34282525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer.
    Lee E; Kang SB; Choi SI; Chun EJ; Kim MJ; Kim DW; Oh HK; Ihn MH; Kim JW; Bang SM; Lee JO; Kim YJ; Kim JH; Lee JS; Lee KW
    Cancer Res Treat; 2016 Jul; 48(3):978-89. PubMed ID: 26582397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thromboembolism After Surgical Treatment of Breast Cancer.
    Momeni A; Fox JP
    Ann Plast Surg; 2018 Feb; 80(2):188-192. PubMed ID: 29095189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing and Risk Factors for Venous Thromboembolism After Rotator Cuff Repair in the 30-Day Perioperative Period.
    Sager B; Ahn J; Tran J; Khazzam M
    Arthroscopy; 2019 Nov; 35(11):3011-3018. PubMed ID: 31629586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of venous thromboembolism during admission for meningioma surgery on hospital charges and postoperative complications.
    Spinazzi EF; Shastri D; Raikundalia M; Silva NA; Eloy JA; Liu JK
    J Clin Neurosci; 2019 Jan; 59():218-223. PubMed ID: 30309806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database.
    Guo JD; Rajpura J; Hlavacek P; Keshishian A; Sah J; Delinger R; Mu Q; Mardekian J; Russ C; Okano GJ; Rosenblatt L
    J Manag Care Spec Pharm; 2020 Aug; 26(8):1017-1026. PubMed ID: 32452277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Preoperative Opioid Exposure on Healthcare Utilization and Expenditures Following Elective Abdominal Surgery.
    Waljee JF; Cron DC; Steiger RM; Zhong L; Englesbe MJ; Brummett CM
    Ann Surg; 2017 Apr; 265(4):715-721. PubMed ID: 28151795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer.
    Connolly GC; Dalal M; Lin J; Khorana AA
    Lung Cancer; 2012 Dec; 78(3):253-8. PubMed ID: 23026639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism.
    Coleman CI; Baugh C; Crivera C; Milentijevic D; Wang SW; Lu L; Nelson WW
    J Med Econ; 2017 Feb; 20(2):200-203. PubMed ID: 27780397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.